Interleukin-1 receptor antagonist (Q34354989)

1 August 2017

1 reference

title

Interleukin-1 receptor antagonist. (English)

1 reference

1 August 2017

Interleukin-1 Receptor Antagonist (English)

0 references

0 references

Arend WP

1

1 reference

1 August 2017

William P. Arend

series ordinal

1

0 references

publication date

1 January 1993

1 reference

1 August 2017

1993

0 references

published in

Advances in Immunology

1 reference

1 August 2017

volume

54

1 reference

1 August 2017

page(s)

167-227

1 reference

A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin-1 receptor antagonist: discovery, structure and properties

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interaction of recombinant monocyte-derived interleukin 1 receptor antagonist with rheumatoid synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Multiple amino acid substitutions suggest a structural basis for the separation of biological activity and receptor binding in a mutant interleukin-1 beta protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin-1 receptor antagonist production by human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Human dermal fibroblast interleukin-1 receptor antagonist (IL-1ra) and interleukin-1 beta (IL-1 beta) mRNA and protein are co-stimulated by phorbol ester: implication for a homeostatic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

High-resolution three-dimensional structure of interleukin 1 beta in solution by three- and four-dimensional nuclear magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Reduced mitogen stimulation of DNA synthesis in human lymphocytes by a human recombinant interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Human recombinant interleukin-1 receptor antagonist inhibits lymphocyte blastogenesis induced by concanavalin A Restorative effect of hrIL-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Blocking the interleukin-1 receptor inhibits leukotriene B4 and prostaglandin E2 generation in human monocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Identification of an interleukin-1 beta binding protein in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

An interleukin-1 receptor antagonist protein protects insulin-producing Beta cells against suppressive effects of interleukin-1?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Role of receptor binding and gene transcription for both the stimulatory and inhibitory effects of interleukin-1 in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Demonstration of IL-1 alpha, and IL-1 beta secretion by the monocytic leukemia cell line, THP-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Characterization of a specific 20- to 25-kD interleukin-1 inhibitor from cultured human lung macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Potentiation of the T-lymphocyte response to mitogens. I. The responding cell

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Production of an interleukin-1 inhibitory factor by human alveolar macrophages from normals and allergic asthmatic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Production of interleukin-1-receptor antagonist during experimental endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin 1 receptor antagonist in human epidermis and cultured keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Peripheral nerve regeneration is impeded by interleukin-1 receptor antagonist released from a polymeric guidance channel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin-1 receptor antagonist in normal and psoriatic epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Inhibition of interleukin-1-induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Human intraovarian interleukin-1 (IL-1) system: highly compartmentalized and hormonally dependent regulation of the genes encoding IL-1, its receptor, and its receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

IL-1 receptor antagonist release is regulated differently in human alveolar macrophages than in monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Expression of interleukin 1-inducible genes and production of interleukin 1 by aging human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Native interleukin 1 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Cloning and chromosome mapping of the human interleukin-1 receptor antagonist gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Localization of Interleukin-1 Receptor Antagonist mRNA in Rat Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Recombinant monocyte-derived interleukin-1 receptor antagonist reverses inhibitory effects of interleukin-1 on Leydig cell steroidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin-1 inhibits cholesterol side-chain cleavage cytochrome P450 expression in primary cultures of Leydig cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

IL-1ra ELISA: reduction and alkylation of synovial fluid eliminates interference by IgM rheumatoid factors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin-1 inhibitor production by human mononuclear leukocytes and leukocyte subpopulations exposed to respiratory syncytial virus: analysis and comparison with the response to influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Selective synthesis and secretion of a 23 kD protein by neutrophils following stimulation with granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Expression and regulation of human alveolar macrophage-derived interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Natural and recombinant interleukin 1 receptor antagonist does not inhibit human T-cell proliferation induced by mitogens, soluble antigens or allogeneic determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin 1 receptor antagonist blocks somnogenic and pyrogenic responses to an interleukin 1 fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Enhancement of growth of virulent strains of Escherichia coli by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Neutral protease secretion by human monocytes. Effect of surface-bound immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Loss of Fc receptor activity after culture of human monocytes on surface-bound immune complexes. Mediation by cyclic nucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

The natural interleukin-1 receptor antagonist prevents interleukin-1-induced preterm delivery in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Activity of an interleukin 1 receptor antagonist in rabbit models of uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin-1-inhibitor activity induced by respiratory syncytial virus: abrogation of virus-specific and alternate human lymphocyte proliferative responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Biochemical and Molecular Actions of Interleukin-1 on Pancreatic β-Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Human monocytes produce IL-1 and an inhibitor of IL-1 in response to two different signals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

An interleukin 1 inhibitor affects both cell-associated interleukin 1-induced T cell proliferation and PGE2/collagenase production by human dermal fibroblasts and synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Modulation of the effects of interleukin-1 on glycosaminoglycan synthesis by the urine-derived interleukin-1 inhibitor, but not by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Production of a 26,000-dalton interleukin 1 inhibitor by human monocytes is regulated by granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Kupffer cells may autoregulate interleukin 1 production by producing interleukin 1 inhibitor and prostaglandin E2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Cloning, heterologous expression and characterization of murine interleukin 1 receptor antagonist protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Cloning the interleukin 1 receptor from human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Effects of fat availability on acetyl-CoA and acetylcarnitine metabolism in rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Induction of neutral proteinase and prostanoid production in bovine nasal chondrocytes by interleukin-1 and tumor necrosis factor alpha: modulation of these cellular responses by interleukin-6 and platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Length variation within intron 2 of the human IL-1 receptor antagonist protein gene (IL1RN)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Human interleukin-1 receptor antagonist is expressed in liver

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Human interleukin-1 receptor antagonist. High yield expression in E. coli and examination of cysteine residues

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Secondary structure and topology of interleukin-1 receptor antagonist protein determined by heteronuclear three-dimensional NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Inhibitor of interleukin 1 in normal human urine. Different effects on mouse thymocytes and on a murine T-cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

A soluble form of the interleukin-1 receptor produced by a human B cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

A soluble binding protein specific for interleukin 1 beta is produced by activated mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Purification and characterization of a novel soluble receptor for interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Characterization of IL-1 inhibitory factor released from human alveolar macrophages as IL-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Evaluation of an interleukin-1 receptor antagonist in the rat acetic acid-induced colitis model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-β

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Secondary structural analysis of two recombinant murine proteins, interleukins 1 alpha and 1 beta: is infrared spectroscopy sufficient to assign structure?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Blockade by interleukin-1 receptor antagonist of IL-1 beta-induced neuronal activity in guinea pig preoptic area slices

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

Monocyte-derived inhibitor of interleukin 1 induced by human cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

The natural interleukin-1 receptor antagonist in term and preterm parturition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960535-0

7 January 2021

10.1016/S0065-2776(08)60535-0

Identifiers

DOI

0 references

1 reference